These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 6932941)

  • 21. Using mathematical models to estimate drug resistance and treatment efficacy via CT scan measurements of tumour volume.
    Gregory WM; Reznek RH; Hallett M; Slevin ML
    Br J Cancer; 1990 Oct; 62(4):671-5. PubMed ID: 2223589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knowing your tumour?
    Tannock IF; Hickman JA
    Lancet Oncol; 2020 Jun; 21(6):e297. PubMed ID: 32502449
    [No Abstract]   [Full Text] [Related]  

  • 23. Multi-energy computed tomography and material quantification: Current barriers and opportunities for advancement.
    Jacobsen MC; Thrower SL; Ger RB; Leng S; Court LE; Brock KK; Tamm EP; Cressman ENK; Cody DD; Layman RR
    Med Phys; 2020 Aug; 47(8):3752-3771. PubMed ID: 32453879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Objective response rate assessment in oncology: Current situation and future expectations.
    Aykan NF; Özatlı T
    World J Clin Oncol; 2020 Feb; 11(2):53-73. PubMed ID: 32133275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Algorithm Variability in the Estimation of Lung Nodule Volume From Phantom CT Scans: Results of the QIBA 3A Public Challenge.
    Athelogou M; Kim HJ; Dima A; Obuchowski N; Peskin A; Gavrielides MA; Petrick N; Saiprasad G; Colditz Colditz D; Beaumont H; Oubel E; Tan Y; Zhao B; Kuhnigk JM; Moltz JH; Orieux G; Gillies RJ; Gu Y; Mantri N; Goldmacher G; Zhang L; Vega E; Bloom M; Jarecha R; Soza G; Tietjen C; Takeguchi T; Yamagata H; Peterson S; Masoud O; Buckler AJ
    Acad Radiol; 2016 Aug; 23(8):940-52. PubMed ID: 27215408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer.
    Chuong MD; Hayman TJ; Patel MR; Russell MS; Malafa MP; Hodul PJ; Springett GM; Choi J; Shridhar R; Hoffe SE
    Gastrointest Cancer Res; 2011 Jul; 4(4):128-34. PubMed ID: 22368736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of tumor volumes improves RECIST-based response assessments in advanced lung cancer.
    Mozley PD; Bendtsen C; Zhao B; Schwartz LH; Thorn M; Rong Y; Zhang L; Perrone A; Korn R; Buckler AJ
    Transl Oncol; 2012 Feb; 5(1):19-25. PubMed ID: 22348172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE.
    Zhang JW; Feng XY; Liu HQ; Yao ZW; Yang YM; Liu B; Yu YQ
    World J Gastroenterol; 2010 Apr; 16(16):2038-45. PubMed ID: 20419843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computerized tomography in the quantitative assessment of tumour response.
    Quivey JM; Castro JR; Chen GT; Moss A; Marks WM
    Br J Cancer Suppl; 1980 Apr; 4():30-4. PubMed ID: 6932941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computerized tomography, diagnostic ultrasound, and radionuclide scanning. Comparison of efficacy in diagnosis of pancreatic carcinoma.
    Barkin J; Vining D; Miale A; Gottlieb S; Redlhammer DE; Kalser MH
    JAMA; 1977 Nov; 238(19):2040-2. PubMed ID: 578902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherapy Hi Art machine: final results of the VortigERN study.
    Chatterjee S; Frew J; Mott J; McCallum H; Stevenson P; Maxwell R; Wilsdon J; Kelly CG
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e173-9. PubMed ID: 23079100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A treatment planning study evaluating a 'simultaneous integrated boost' technique for accelerated radiotherapy of stage III non-small cell lung cancer.
    Dirkx ML; van Sörnsen De Koste JR; Senan S
    Lung Cancer; 2004 Jul; 45(1):57-65. PubMed ID: 15196735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour volume: implications in T2/T3 glottic/supraglottic squamous cell carcinoma.
    Lo SM; Venkatesan V; Matthews TW; Rogers J
    J Otolaryngol; 1998 Oct; 27(5):247-51. PubMed ID: 9800621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas.
    Fukumoto S; Shirato H; Shimzu S; Ogura S; Onimaru R; Kitamura K; Yamazaki K; Miyasaka K; Nishimura M; Dosaka-Akita H
    Cancer; 2002 Oct; 95(7):1546-53. PubMed ID: 12237924
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.